164 related articles for article (PubMed ID: 25993660)
1. Evidence that selenium binding protein 1 is a tumor suppressor in prostate cancer.
Ansong E; Ying Q; Ekoue DN; Deaton R; Hall AR; Kajdacsy-Balla A; Yang W; Gann PH; Diamond AM
PLoS One; 2015; 10(5):e0127295. PubMed ID: 25993660
[TBL] [Abstract][Full Text] [Related]
2. Selenium-binding protein 1 alters energy metabolism in prostate cancer cells.
Elhodaky M; Hong LK; Kadkol S; Diamond AM
Prostate; 2020 Sep; 80(12):962-976. PubMed ID: 32511787
[TBL] [Abstract][Full Text] [Related]
3. Selenium-Binding Protein 1 in Human Health and Disease.
Elhodaky M; Diamond AM
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400135
[TBL] [Abstract][Full Text] [Related]
4. Inverse association between glutathione peroxidase activity and both selenium-binding protein 1 levels and Gleason score in human prostate tissue.
Jerome-Morais A; Wright ME; Liu R; Yang W; Jackson MI; Combs GF; Diamond AM
Prostate; 2012 Jun; 72(9):1006-12. PubMed ID: 22072582
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of selenium-binding protein 1 is associated with poor prognosis in lung squamous cell carcinoma.
Tan X; Liao L; Wan YP; Li MX; Chen SH; Mo WJ; Zhao QL; Huang LF; Zeng GQ
World J Surg Oncol; 2016 Mar; 14():70. PubMed ID: 26956891
[TBL] [Abstract][Full Text] [Related]
6. Subcellular localization of p27 and prostate cancer recurrence: automated digital microscopy analysis of tissue microarrays.
Ananthanarayanan V; Deaton RJ; Amatya A; Macias V; Luther E; Kajdacsy-Balla A; Gann PH
Hum Pathol; 2011 Jun; 42(6):873-81. PubMed ID: 21292307
[TBL] [Abstract][Full Text] [Related]
7. CD147 expression predicts biochemical recurrence after prostatectomy independent of histologic and pathologic features.
Bauman TM; Ewald JA; Huang W; Ricke WA
BMC Cancer; 2015 Jul; 15():549. PubMed ID: 26209327
[TBL] [Abstract][Full Text] [Related]
8. A Critical Role for Cysteine 57 in the Biological Functions of Selenium Binding Protein-1.
Ying Q; Ansong E; Diamond AM; Yang W
Int J Mol Sci; 2015 Nov; 16(11):27599-608. PubMed ID: 26593911
[TBL] [Abstract][Full Text] [Related]
9. Decreased selenium-binding protein 1 enhances glutathione peroxidase 1 activity and downregulates HIF-1α to promote hepatocellular carcinoma invasiveness.
Huang C; Ding G; Gu C; Zhou J; Kuang M; Ji Y; He Y; Kondo T; Fan J
Clin Cancer Res; 2012 Jun; 18(11):3042-53. PubMed ID: 22512980
[TBL] [Abstract][Full Text] [Related]
10. Reduction of selenium-binding protein 1 sensitizes cancer cells to selenite via elevating extracellular glutathione: a novel mechanism of cancer-specific cytotoxicity of selenite.
Wang Y; Fang W; Huang Y; Hu F; Ying Q; Yang W; Xiong B
Free Radic Biol Med; 2015 Feb; 79():186-96. PubMed ID: 25445402
[TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
12. Loss of PTEN Expression Detected by Fluorescence Immunohistochemistry Predicts Lethal Prostate Cancer in Men Treated with Prostatectomy.
Hamid AA; Gray KP; Huang Y; Bowden M; Pomerantz M; Loda M; Sweeney CJ
Eur Urol Oncol; 2019 Sep; 2(5):475-482. PubMed ID: 31411988
[TBL] [Abstract][Full Text] [Related]
13. Nuclear Shape and Architecture in Benign Fields Predict Biochemical Recurrence in Prostate Cancer Patients Following Radical Prostatectomy: Preliminary Findings.
Lee G; Veltri RW; Zhu G; Ali S; Epstein JI; Madabhushi A
Eur Urol Focus; 2017 Oct; 3(4-5):457-466. PubMed ID: 28753763
[TBL] [Abstract][Full Text] [Related]
14. Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer.
Zellweger T; Günther S; Zlobec I; Savic S; Sauter G; Moch H; Mattarelli G; Eichenberger T; Curschellas E; Rüfenacht H; Bachmann A; Gasser TC; Mihatsch MJ; Bubendorf L
Int J Cancer; 2009 May; 124(9):2116-23. PubMed ID: 19117060
[TBL] [Abstract][Full Text] [Related]
15. Sodium Selenite Inhibits Proliferation of Gastric Cancer Cells by Inducing SBP1 Expression.
Gong J; Li L
Tohoku J Exp Med; 2016 Aug; 239(4):279-85. PubMed ID: 27477809
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence.
Tsourlakis MC; Schoop M; Plass C; Huland H; Graefen M; Steuber T; Schlomm T; Simon R; Sauter G; Sirma H; Minner S
Hum Pathol; 2013 Sep; 44(9):1789-96. PubMed ID: 23642739
[TBL] [Abstract][Full Text] [Related]
17. SIGIRR/TIR8, an important regulator of TLR4 and IL-1R-mediated NF-κB activation, predicts biochemical recurrence after prostatectomy in low-grade prostate carcinomas.
Bauman TM; Becka AJ; Sehgal PD; Huang W; Ricke WA
Hum Pathol; 2015 Nov; 46(11):1744-51. PubMed ID: 26344417
[TBL] [Abstract][Full Text] [Related]
18. Seminal plasma proteins in prostatic carcinoma: increased nuclear semenogelin I expression is a predictor of biochemical recurrence after radical prostatectomy.
Izumi K; Li Y; Zheng Y; Gordetsky J; Yao JL; Miyamoto H
Hum Pathol; 2012 Nov; 43(11):1991-2000. PubMed ID: 22617231
[TBL] [Abstract][Full Text] [Related]
19. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
Zhou M; Hayasaka S; Taylor JM; Shah R; Proverbs-Singh T; Manley S; Rubin MA
J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734
[TBL] [Abstract][Full Text] [Related]
20. Low Tristetraprolin Expression Is Associated with Lethal Prostate Cancer.
Gerke T; Beltran H; Wang X; Lee GM; Sboner A; Karnes RJ; Klein EA; Davicioni E; Yousefi K; Ross AE; Börnigen D; Huttenhower C; Mucci LA; Trock BJ; Sweeney CJ
Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):584-590. PubMed ID: 30420441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
